Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Y Dodd

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Transfusion|March 3, 1998
Current status of solvent/detergent-treated frozen plasmaH G Klein, R Y Dodd, W H Dzik, et al.
Vox Sanguinis|January 1, 1995
Study of HIV antibody screening for blood donors by a pooling-serum methodY Ji, D Qu, G Jia, et al.
Transfusion|February 1, 1995
Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donorsM P Busch, L L Lee, G A Satten, et al.
The New England Journal of Medicine|December 28, 1995
Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United StatesE M Lackritz, G A Satten, J Aberle-Grasse, et al.
Science (New York, N.Y.)|March 23, 1984
Transfusion-associated AIDS: serologic evidence of human T-cell leukemia virus infection of donorsH W Jaffe, D P Francis, M F McLane, et al.
Transfusion|June 16, 2001
Seroprevalence of known and putative hepatitis markers in United States blood donors with ALT levels at least 120 IU per LE P Notari, S L Orton, R G Cable, et al.
Vox Sanguinis|August 6, 1998
Consequences of nucleic acid amplification testing for blood transfusion centresH W Reesink, C P Engelfriet, H Vrielink, et al.
Vox Sanguinis|February 9, 2010
The use of malaria antibody tests in the prevention of transfusion-transmitted malariaH W Reesink, S Panzer, S Wendel, et al.
Vox Sanguinis|August 20, 2003
Future counselling of donors and recipients of blood products concerning prion-related diseasesH W Reesink, C P Engelfriet, L Muylle, et al.
Vox Sanguinis|August 24, 2010
Research and developmentD V Devine, H W Reesink, S Panzer, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Transfusion|March 3, 1998
Current status of solvent/detergent-treated frozen plasmaH G Klein, R Y Dodd, W H Dzik, et al.
Vox Sanguinis|January 1, 1995
Study of HIV antibody screening for blood donors by a pooling-serum methodY Ji, D Qu, G Jia, et al.
Transfusion|February 1, 1995
Time course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donorsM P Busch, L L Lee, G A Satten, et al.
The New England Journal of Medicine|December 28, 1995
Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United StatesE M Lackritz, G A Satten, J Aberle-Grasse, et al.
Science (New York, N.Y.)|March 23, 1984
Transfusion-associated AIDS: serologic evidence of human T-cell leukemia virus infection of donorsH W Jaffe, D P Francis, M F McLane, et al.
Transfusion|June 16, 2001
Seroprevalence of known and putative hepatitis markers in United States blood donors with ALT levels at least 120 IU per LE P Notari, S L Orton, R G Cable, et al.
Vox Sanguinis|August 6, 1998
Consequences of nucleic acid amplification testing for blood transfusion centresH W Reesink, C P Engelfriet, H Vrielink, et al.
Vox Sanguinis|February 9, 2010
The use of malaria antibody tests in the prevention of transfusion-transmitted malariaH W Reesink, S Panzer, S Wendel, et al.
Vox Sanguinis|August 20, 2003
Future counselling of donors and recipients of blood products concerning prion-related diseasesH W Reesink, C P Engelfriet, L Muylle, et al.
Vox Sanguinis|August 24, 2010
Research and developmentD V Devine, H W Reesink, S Panzer, et al.
Pageof 12